Each year, more than 8000 allogeneic stem cell transplantations (allo-SCT) are performed in
the United States, with approximately 30% of these patients age≥ 60 years. Allo-SCT …

Squamous cell carcinoma (SCC) is among the most common secondary cancers after
allogeneic stem cell transplantation (allo-SCT). Several types of human papillomavirus …

The association between squamous cell carcinoma (SCC) of the oral cavity, female genital
tract, and skin with human papilloma virus (HPV) subtypes is well established in the general …

This longitudinal single-center study describes the timing and risk factors for genital human
papillomavirus (HPV) disease in women after allogeneic hematopoietic cell transplantation …

As more women survive allogeneic stem cell transplantation (SCT), the development of
genital human papilloma virus (HPV)-related squamous intraepithelial lesions (SIL) warrants …

The clinical manifestations of human papilloma virus (HPV) infection are vast, ranging from
common warts to squamous cell carcinomas (SCCs). Immunodeficient populations are …

Methods: This was a phase 3, multicenter, open-label, randomized, controlled trial in
patients< 18 years, with myeloablative conditioning before allogeneic or autologous SCT …

Transplant recipients have elevated cancer risk including risk of human papillomavirus
(HPV)-associated cancers of the cervix, anus, penis, vagina, vulva and oropharynx. We …

Hematopoietic cell transplantation (HCT) results in long-term survival (≥ 10 years) in 85% of
patients who survive transplant-related complications within the first 2 years posttransplant …

Purpose To provide a narrative review of anogenital screening for human papillomavirus in
solid organ transplant recipients. Methods Keyword searches of PubMed and Ovid …